Bioelectronics Corp (BIEL)

[luke5516]

We are fine. I’d love to see it go up every day, but management is clearly busy ain’t important business.

It should not be at sub-penny levels. IMO, a fair valuation based on recent public updates and growth potential would be somewhere between .01 and .05.

The fact that BIEL has not dipped back to triple zeros and we are holding in the high .006’s shows we crossed into a new level of share price and shareholder value.

IMO, we don’t need PRs any more to prop up the SP. Even with zero PRs, the regular rhythm of quarterly financials will take us where we need to go.

It’s almost March, quarter closes at the end of March, they may give a early look/preview like they did in January for 2020z

We will be fine. Just think about $500k I’m deferred revenue plus 15 pallet order (almost certainly worth more than $500) - deferred interest payments = could equal record quarter.

A record quarter would have to beat the quarters when OTC sales were really humming in the UK before the CE mark expired and they recalibrated to take ActiPatch sales behind the pharmacists counter there.

And depending on when that ship load hits the books as accounts receivable or recognized revenue, we will get a U.K. boost in this quarter as well.

Plus whatever BIEL May have been paid for the semi exclusive distribution rights from our three partners.